Provided by Tiger Trade Technology Pte. Ltd.

Legend Biotech

19.32
-0.5700-2.87%
Post-market: 19.26-0.0600-0.31%18:57 EDT
Volume:2.22M
Turnover:43.05M
Market Cap:3.76B
PE:-38.58
High:19.78
Open:19.61
Low:19.19
Close:19.89
52wk High:37.50
52wk Low:16.24
Shares:194.49M
Float Shares:91.34M
Volume Ratio:1.13
T/O Rate:2.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5008
EPS(LYR):-1.6200
ROE:-8.08%
ROA:-1.92%
PB:3.06
PE(LYR):-11.93

Loading ...

Legend Biotech Q1 Adj. EPS $(0.03) Misses $(0.02) Estimate, Sales $305.100M Miss $307.035M Estimate

Benzinga Earnings
·
May 12

Legend Biotech Corp - Reports Cash and Cash Equivalents, Time Deposits of $834.6 Mln as of March 31, 2026

THOMSON REUTERS
·
May 12

Legend Biotech Corporation Q1 Pretax Profit USD -53.1 Million

THOMSON REUTERS
·
May 12

Legend Biotech Corporation Q1 Adjusted EPS USD -0.03 VS. Ibes Estimate USD -0.02

THOMSON REUTERS
·
May 12

Legend Biotech Reports First Quarter 2026 Results and Recent Highlights

GlobeNewswire
·
May 12

Legend Biotech's Q1 2026 Earnings Preview: CARVYKTI Sales Projected at Approximately $597 Million

Deep News
·
May 11

Earning Preview: Legend Biotech Q1 revenue is expected to increase by 58.58%, and institutional views are bullish

Earnings Agent
·
May 05

Legend Biotech Expands Scientific Advisory Expertise to Inform Future Growth

GlobeNewswire
·
May 04

Is Growing Focus On CAR-T Data And CARVYKTI Orders Reframing Legend Biotech’s (LEGN) Investment Story?

Simply Wall St.
·
May 02

Legend Biotech to Host Investor Conference Call on First Quarter 2026 Results

GlobeNewswire
·
Apr 28

Legend Biotech Soars Over 40% in 5 Days: Is Lilly's $7B Bet Revealing a Deeply Undervalued Gem?

Stock News
·
Apr 22

Legend Biotech Price Target Maintained With a $50.00/Share by HC Wainwright & Co.

Dow Jones
·
Apr 21

Analysts Offer Insights on Healthcare Companies: 10x Genomics (TXG), Arrowhead Pharmaceuticals (ARWR) and Legend Biotech (LEGN)

TIPRANKS
·
Apr 20

Legend Biotech Price Target Maintained With a $50.00/Share by HC Wainwright & Co.

Dow Jones
·
Apr 15

BUZZ-Genscript Biotech climbs as cancer drug CARVYKTI generated $597 mln sales

Reuters
·
Apr 15

Legend Biotech Reports Preliminary Q1 2026 CARVYKTI Sales of About $597 Million

TIPRANKS
·
Apr 14

RBC Capital Sticks to Their Buy Rating for Legend Biotech (LEGN)

TIPRANKS
·
Apr 09